LLY
Eli Lilly and Company
Eli Lilly and Company historical holders
total: 12
Jensen Investment Management Eli Lilly and Company transactions over time
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 4
- Held since:
- 2025 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q1
Eric H. Schoenstein has been an institutional investor in Eli Lilly and Company (LLY) since 2013 Q3. According to 2026 Q1 report, Eric H. Schoenstein holds 230,671 shares with a market value of roughly $212.16M representing 4.18% of their equity portfolio. The fund/company first acquired LLY in 2013 Q3, initially purchasing 8,400 shares. Eric H. Schoenstein later completely sold out the position and reinvested in LLY again in 2025 Q2. Since the initial investment, Jensen Investment Management has made 8 more transactions in this position.
Does Eric H. Schoenstein still hold LLY?
Yes, Eric H. Schoenstein continues to hold Eli Lilly and Company (LLY). According to their 2026 Q1 report, they maintain a position of 230,671 shares valued at approximately $212.16M, representing 4.18% of their equity portfolio.
When did Eric H. Schoenstein first invest in LLY?
Eric H. Schoenstein first invested in Eli Lilly and Company (LLY) in 2013 Q3 at the reported quarter-end price of $50.36 per share, acquiring 8,400 shares in their initial purchase.
What is Eric H. Schoenstein's average cost basis for LLY?
Based on historical transaction data, Eric H. Schoenstein's estimated cost basis for Eli Lilly and Company (LLY) is approximately $770.37 per share. This represents their average reported price* across all buy transactions.
Has Eric H. Schoenstein reinvested in LLY after selling?
Yes, Eric H. Schoenstein has shown renewed interest in Eli Lilly and Company (LLY). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $770.36
- Weighted AVG sell price:
- $1,061.95
LLY transactions history by Jensen Investment Management
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
4.18%
|
230,671
|
$919.77
|
$212,164,266
|
-7.67% (-19,156)
|
-0.28%
|
|
2025 Q4
|
4.22%
|
249,827
|
$1,074.68
|
$268,484,080
|
-46.13% (-213,912)
|
-2.85%
|
|
2025 Q3
|
4.39%
|
463,739
|
$763.00
|
$353,832,857
|
+124.45% (+257,127)
|
+2.43%
|
|
2025 Q2
|
1.89%
|
206,612
|
$779.53
|
$161,060,252
|
new
|
+1.89%
|
|
2014 Q3
|
0.00%
|
$62.18
|
-100% (-7,720)
|
|||
|
2014 Q2
|
0.01%
|
$62.18
|
-15.35% (-1,400)
|
|||
|
2014 Q1
|
0.01%
|
$58.88
|
-8.98% (-900)
|
|||
|
2013 Q4
|
0.01%
|
$51.00
|
+19.29% (+1,620)
|
|||
|
2013 Q3
|
0.01%
|
$50.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.